Alnylam Pharmaceuticals, Inc.

NEW YORK STATE COMMON RETIREMENT FUND ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

64,424

Value ($000)

25,618

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	25,618	0.0%	64,424	12/31/2025
2025 Q3	11/3/2025	29,377	0.0%	64,424	9/30/2025
2025 Q2	10/8/2025	20,632	0.0%	63,272	6/30/2025
2025 Q1	10/8/2025	17,355	0.0%	64,272	3/31/2025
2024 Q4	10/8/2025	16,996	0.0%	72,228	12/31/2024
2024 Q3	10/8/2025	20,965	0.0%	76,228	9/30/2024
2024 Q2	10/8/2025	23,008	0.0%	94,685	6/30/2024
2024 Q1	10/8/2025	14,013	0.0%	93,766	3/31/2024
2023 Q4	10/8/2025	21,421	0.0%	111,914	12/31/2023
2023 Q3	10/8/2025	22,131	0.0%	124,963	9/30/2023
2023 Q2	10/8/2025	26,994	0.0%	142,119	6/30/2023
2023 Q1	10/8/2025	29,665	0.0%	148,088	3/31/2023
2022 Q4	10/8/2025	36,764	0.1%	154,698	12/31/2022
2022 Q3	11/8/2022	29,627	0.0%	148,018	9/30/2022
2022 Q2	8/4/2022	22,333	0.0%	153,124	6/30/2022
2022 Q1	7/1/2022	30,486	0.0%	186,700	3/31/2022
2021 Q4	2/2/2022	31,820	0.0%	187,641	12/31/2021
2021 Q3	11/2/2021	34,160	0.0%	180,924	9/30/2021
2021 Q2	8/2/2021	31,212	0.0%	184,120	6/30/2021
2021 Q1	5/11/2021	26,043	0.0%	184,454	3/31/2021
2020 Q4	2/8/2021	25,806	0.0%	198,554	12/31/2020
2020 Q3	11/5/2020	31,996	0.0%	219,754	9/30/2020
2020 Q2	8/7/2020	35,924	0.0%	242,549	6/30/2020
2020 Q1	5/6/2020	26,149	0.0%	240,229	3/31/2020
2019 Q4	2/5/2020	29,175	0.0%	253,320	12/31/2019
2014 Q2	8/5/2014	8,527	0.0%	134,989	6/30/2014
2014 Q1	5/5/2014	8,167	0.0%	121,640	3/31/2014
2013 Q4	2/7/2014	5,469	0.0%	85,017	12/31/2013